Wednesday, June 10, 2020 6:33:58 AM
Schena was born in Buffalo, New York. He received his B.A. in biochemistry from Daniel E. Koshland, Jr. at the University of California at Berkeley in 1984. Schena received his Ph.D. in biochemistry from the University of California, San Francisco (UCSF) in 1990. Schena studied as a postdoctoral fellow in the Department of Biochemistry at Stanford University from 1990 until 1999.
Career
During his studies at Berkeley, Schena showed that changes in citrate synthase expression cause changes in flux through the citric acid cycle.[1] This work showed the importance of rate limiting steps in enzymatic pathways. As a graduate student at UCSF, Schena discovered the evolutionary conservation of cellular mechanisms across eukaryotic evolution by demonstrating the conservation of mammalian glucocorticoid receptor function in the yeast Saccharomyces cerevisiae.[2] At Stanford, Schena pioneered a new field of science (microarray technology) as the first author on the Stanford team publication in the journal Science demonstrating that complementary DNA molecules immobilized on glass could be used to measure gene expression in the flowering plant Arabidopsis thaliana.[3] The modern microarray industry and solid-phase DNA sequencing industry have drawn heavily from the 1995 Science paper. More than 42,000 peer-reviewed microarray publications have appeared in the scientific literature since 1995.[4]
Schena has written four books on microarrays,[5][6][7][8] including the first textbook on the subject,[9] and has been featured by journalists in interviews covered by the print media, radio and television.[10] Schena has pioneered an extensive line of microarray products and services at Arrayit[clarification needed]. Schena is the inventor of Variation Identification Platform (VIP) technology, which is capable of genotyping up to 80,000 patients in a single microarray test.[11] Schena has taken an active role in healthcare reform in the United States by promoting the importance of technical innovation as a means of improving the quality and accessibility of healthcare and controlling its cost.[12] Schena is considered the foremost authority on microarray technology, referred to as the "Father of Microarray Technology".[13]
In 2001, Schena was featured on the Nova television documentary "Cracking the Code of Life", a two-hour special hosted by ABC News Nightline correspondent Robert Krulwich.[14] Schena first introduced microarrays as pre-symptomatic diagnostic tools on the 2001 Nova program. Schena holds the first and second positions on "The Microarray Family Tree", a historiograph of 13 influential papers published in the microarray field, written by Eugene Garfield.[15] The Scientist also credited Schena with creating the first array.[16] Schena was proclaimed the "Father of Microarrays" in an article written by Lloyd Dunlap, contributing editor of Drug Discovery News, in an account of Schena's pioneering work to decipher Parkinson's disease.[17] Schena and Rene Schena reside in Los Altos, California.[citation needed]
References
Walsh, K., Schena, M., Flint, A.J., and D.E. Koshland. Compensatory regulation in metabolic pathways- responses to increases and decreases in citrate synthase levels. Biochemistry Society Symposia 54, 183–195, 1987.
Schena, M. and K.R. Yamamoto. Mammalian glucocorticoid receptor derivatives enhance transcription in yeast. Science 241, 965–967, 1988.
Schena, M., Shalon, D., Davis, R.W. and P.O. Brown. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467–470, 1995.
(enter search term “microarray or microarrays or microarrayer or microarrayed or microarraying”
(DNA Microarrays: A Practical Approach, first book on microarrays, edited by Mark Schena, Oxford University Press, Oxford, United Kingdom, pp. 232, 1999.
Microarray Biochip Technology. First concepts book on DNA microarrays, edited by Mark Schena, BioTechniques Book Division, Eaton Publishing, Natick, Massachusetts, USA, pp. 347, 2000.
Protein Microarrays. First comprehensive book on protein-based microarrays and proteomics, edited by Mark Schena, Jones and Bartlett Publishers, Inc., Sudbury, Massachusetts, USA, pp. 469, 2004
DNA Microarrays-Methods Express. First microarray methods book on the latest applications of DNA microarrays including whole human genome microarrays, edited by Mark Schena, Scion Publishing Ltd., Bloxham, U.K, pp. 350, 2007.)
Schena, M. Microarray Analysis. First Textbook on Microarray Analysis, 1st Edition, J. Wiley & Sons, Hoboken, NJ, pp. 648, 2003.
(see media coverage) Archived 2011-07-07 at the Wayback Machine.
http://arrayit.com/Microarray_Diagnostics/microarray_diagnostics.html .
"Archived copy". Archived from the original on 2010-02-24. Retrieved 2010-02-08.
Sharma, Vinay (2008). Text Book of Bioinformatics. Rastogi Publications. ISBN 9788171339174. Retrieved 2018-12-17.
https://www.pbs.org/wgbh/nova/genome/
Eugene Garfield, The Microarray Family Tree: A historiograph of 13 influential papers. The Scientist, 17(16):29, 2003.
The First Array, The Scientist, 17(16):18, 2003.
Lloyd Dunlap, The "father of microarrays" attacks Parkinson's, Drug Discovery News 5 (5):34, 2009.
Authority control Edit this at Wikidata
BNF: cb14538716f (data)ISNI: 0000 0001 2019 5499LCCN: n99007566NKC: xx0134796NTA: 242985068SUDOC: 070722544VIAF: 248593WorldCat Identities: lccn-n99007566
Categories: 1963 birthsAmerican biochemistsLiving people
https://en.wikipedia.org/wiki/Mark_Schena
https://www.sfchronicle.com/business/article/Sunnyvale-medical-technology-executive-charged-15328319.php
https://www.washingtonpost.com/technology/2020/06/09/arrayit-covid-fraud-charge/
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM